By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
X-Chem Announces Strategic Collaboration With Astellas (ALPMY) Across Multiple Therapeutic Areas 3/20/2017 6:51:25 AM
Gates-Backed Cambridge Startup Affinivax Grabs $10 Million+ Deal With Japanese Drug Giant Astellas (ALPMY) 2/28/2017 6:58:28 AM
Astellas (ALPMY) Names Linda Friedman General Counsel For Worldwide Legal Organization And Executive Committee Member 2/8/2017 9:38:04 AM
GenomeDx Biosciences Announces Research Collaboration With Astellas (ALPMY) To Identify Genomic Drivers Of Patient Response To XTANDI (Enzalutamide) Capsules 2/1/2017 8:38:16 AM
Astellas (ALPMY) Reports The First Nine Months Financial Results Of FY2016 1/31/2017 9:25:28 AM
Astellas (ALPMY) Release: Pharma Announces Participation In Access Accelerated 1/18/2017 12:01:37 PM
Astellas (ALPMY) Completes Acquisition Of Ganymed 12/21/2016 12:17:31 PM
Astellas (ALPMY) Announces FDA Fast Track Designation For ASP0892, DNA Vaccine For Mitigation Of Severe Hypersensitivity Reactions Due To Peanut Allergy 12/20/2016 9:27:15 AM
Pfizer (PFE) And Astellas (ALPMY) Announce Top-Line Results From Phase 4 PLATO Trial Of XTANDI (Enzalutamide) Capsules In Patients With Metastatic Castration-Resistant Prostate Cancer 12/15/2016 12:23:17 PM
Astellas (ALPMY) Renews Commitment With CUA-CUOG To Advance Uro-Oncology Research In Canada 12/5/2016 10:22:21 AM